Offer - Urjas Oil for just ₹ 1 X
Gemcitapar is a prescription drug, available for use as Injection. Pancreatic Cancer, Non-Small Cell Lung Cancer are some of its major therapeutic uses. Other than this, Gemcitapar has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Gemcitapar. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Gemcitapar as well, which are listed below. These side effects of Gemcitapar are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Gemcitapar has a Unknown effect for pregnant women and Severe effect on lactating mothers. It is important to know if Gemcitapar has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Gemcitapar related warnings section.
Individuals suffering from medical conditions like Heart Disease, Infections must refrain from the use of Gemcitapar since this can cause severe adverse effects. Some other conditions that can be affected by Gemcitapar are listed in the contraindications section below.
Additionally, Gemcitapar may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Gemcitapar is safe while driving, and is is addictive in nature.
Gemcitapar is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Adult |
|
Geriatric |
|
Is the use of Gemcitapar safe for pregnant women?
The effects of Gemcitapar on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Gemcitapar safe during breastfeeding?
Taking Gemcitapar may lead to serious side effects if you are breastfeeding. Gemcitapar should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Gemcitapar on the Kidneys?
Gemcitapar has very mild side effects on the kidneys.
What is the effect of Gemcitapar on the Liver?
You may experience side effects on your liver after taking Gemcitapar. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Gemcitapar on the Heart?
Gemcitapar has very mild side effects on the heart.
Gemcitapar should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gemcitapar unless your doctor advises you to do so -
Is this Gemcitapar habit forming or addictive?
Forming a habit of Gemcitapar has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Gemcitapar does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Gemcitapar should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Gemcitapar in mental disorders is not effective.
Interaction between Food and Gemcitapar
There is no information on the effects of taking Gemcitapar with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Gemcitapar
No research has been done on this till date. Therefore, it is not known what the effect of taking Gemcitapar with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gemzar® (Gemcitabine HCl)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 612-614